These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 35430799)

  • 21. Colorectal liver metastases: Current management and future perspectives.
    Martin J; Petrillo A; Smyth EC; Shaida N; Khwaja S; Cheow HK; Duckworth A; Heister P; Praseedom R; Jah A; Balakrishnan A; Harper S; Liau S; Kosmoliaptsis V; Huguet E
    World J Clin Oncol; 2020 Oct; 11(10):761-808. PubMed ID: 33200074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Oncologic Outcomes After Laparoscopic Versus Open Resection for Colorectal Liver Metastases : A Randomized Trial.
    Aghayan DL; Kazaryan AM; Dagenborg VJ; Røsok BI; Fagerland MW; Waaler Bjørnelv GM; Kristiansen R; Flatmark K; Fretland ÅA; Edwin B;
    Ann Intern Med; 2021 Feb; 174(2):175-182. PubMed ID: 33197213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer liver metastases within the central and peripheral segments: Parenchymal sparing surgery adaptation.
    Burlaka AA; Paliichuk AV; Iatsyna OI; Kolesnik ОО
    Ann Med Surg (Lond); 2020 Oct; 58():8-13. PubMed ID: 32874570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Treatment of Colorectal Liver Metastasis as a Chronic Disease.
    Dörr NM; Bartels M; Morgul MH
    Anticancer Res; 2020 Jan; 40(1):1-7. PubMed ID: 31892548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing the Quality of Colorectal Cancer Screening Worldwide.
    Kaminski MF; Robertson DJ; Senore C; Rex DK
    Gastroenterology; 2020 Jan; 158(2):404-417. PubMed ID: 31759062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoprevention of Colorectal Cancer.
    Katona BW; Weiss JM
    Gastroenterology; 2020 Jan; 158(2):368-388. PubMed ID: 31563626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy.
    Kawaguchi Y; Lillemoe HA; Vauthey JN
    J Surg Oncol; 2019 Apr; 119(5):594-603. PubMed ID: 30825223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
    Moris D; Ronnekleiv-Kelly S; Kostakis ID; Tsilimigras DI; Beal EW; Papalampros A; Dimitroulis D; Felekouras E; Pawlik TM
    World J Surg; 2018 Mar; 42(3):806-815. PubMed ID: 28798996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review.
    Moris D; Ronnekleiv-Kelly S; Rahnemai-Azar AA; Felekouras E; Dillhoff M; Schmidt C; Pawlik TM
    J Gastrointest Surg; 2017 Jun; 21(6):1076-1085. PubMed ID: 28364212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extending the Limits of Resection for Colorectal Liver Metastases ENHANCED ONE STAGE SURGERY.
    Torzilli G; Cimino MM
    J Gastrointest Surg; 2017 Jan; 21(1):187-189. PubMed ID: 27561637
    [No Abstract]   [Full Text] [Related]  

  • 31. Drop-out between the two liver resections of two-stage hepatectomy. Patient selection or loss of chance?
    Viganò L; Torzilli G; Cimino M; Imai K; Vibert E; Donadon M; Castaing D; Adam R
    Eur J Surg Oncol; 2016 Sep; 42(9):1385-93. PubMed ID: 27316601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining Post Hepatectomy Liver Insufficiency: Where do We stand?
    Lafaro K; Buettner S; Maqsood H; Wagner D; Bagante F; Spolverato G; Xu L; Kamel I; Pawlik TM
    J Gastrointest Surg; 2015 Nov; 19(11):2079-92. PubMed ID: 26063080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-stage hepatectomy versus 1-stage resection combined with radiofrequency for bilobar colorectal metastases: a case-matched analysis of surgical and oncological outcomes.
    Faitot F; Faron M; Adam R; Elias D; Cimino M; Cherqui D; Vibert E; Castaing D; Cunha AS; Goéré D
    Ann Surg; 2014 Nov; 260(5):822-7; discussion 827-8. PubMed ID: 25379853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours.
    Krausch M; Raffel A; Anlauf M; Schott M; Lehwald N; Krieg A; Topp SA; Cupisti K; Knoefel WT
    World J Surg; 2014 Feb; 38(2):392-401. PubMed ID: 24101025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach.
    Torzilli G; Procopio F; Botea F; Marconi M; Del Fabbro D; Donadon M; Palmisano A; Spinelli A; Montorsi M
    Surgery; 2009 Jul; 146(1):60-71. PubMed ID: 19541011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parenchyma-sparing strategy and oncological prognosis in patients with colorectal cancer liver metastases.
    Burlaka AA; Makhmudov DE; Lisnyi II; Paliichuk AV; Zvirych VV; Lukashenko AV
    World J Surg Oncol; 2022 Apr; 20(1):122. PubMed ID: 35430799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parenchymal sparing surgery brings treatment of colorectal liver metastases into the precision medicine era.
    Evrard S; Torzilli G; Caballero C; Bonhomme B
    Eur J Cancer; 2018 Nov; 104():195-200. PubMed ID: 30380461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature.
    Ramírez-Plaza CP; Moreno-Ruiz FJ; Pérez-Daga JA
    World J Surg Oncol; 2015 Aug; 13():233. PubMed ID: 26231227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parenchyma-sparing liver resections.
    Torzilli G; McCormack L; Pawlik T
    Int J Surg; 2020 Oct; 82S():192-197. PubMed ID: 32335245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes.
    Moris D; Dimitroulis D; Vernadakis S; Papalampros A; Spartalis E; Petrou A; Pawlik TM; Felekouras E
    Anticancer Res; 2017 Jan; 37(1):9-14. PubMed ID: 28011468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.